Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT.

Hull MA, Sprange K, Hepburn T, Tan W, Shafayat A, Rees CJ, Clifford G, Logan RF, Loadman PM, Williams EA, Whitham D, Montgomery AA.

Southampton (UK): NIHR Journals Library; 2019 Jun.

2.

Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.

Chapman C, Bunce J, Oliver S, Ng O, Tangri A, Rogers R, Logan RF, Humes DJ, Banerjea A.

BJS Open. 2019 Jan 28;3(3):395-402. doi: 10.1002/bjs5.50131. eCollection 2019 Jun.

3.

Mortality in people with coeliac disease: Long-term follow-up from a Scottish cohort.

Quarpong W, Card TR, West J, Solaymani-Dodaran M, Logan RF, Grainge MJ.

United European Gastroenterol J. 2019 Apr;7(3):377-387. doi: 10.1177/2050640618814662. Epub 2018 Nov 18.

4.

Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.

Hull MA, Sprange K, Hepburn T, Tan W, Shafayat A, Rees CJ, Clifford G, Logan RF, Loadman PM, Williams EA, Whitham D, Montgomery AA; seAFOod Collaborative Group.

Lancet. 2018 Dec 15;392(10164):2583-2594. doi: 10.1016/S0140-6736(18)31775-6. Epub 2018 Nov 19.

5.

Could stool collection devices help increase uptake in bowel cancer screening programmes?

Morling JR, Barke AN, Chapman CJ, Logan RF.

J Med Screen. 2018 Dec;25(4):174-177. doi: 10.1177/0969141317753463. Epub 2018 Feb 5.

PMID:
29402168
6.

Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.

Smith SG, Wardle J, Atkin W, Raine R, McGregor LM, Vart G, Morris S, Duffy SW, Moss S, Hackshaw A, Halloran S, Kralj-Hans I, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas M, Counsell N, von Wagner C.

BMC Cancer. 2017 Aug 14;17(1):543. doi: 10.1186/s12885-017-3512-1.

7.

Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials.

Odutayo A, Desborough MJ, Trivella M, Stanley AJ, Dorée C, Collins GS, Hopewell S, Brunskill SJ, Kahan BC, Logan RF, Barkun AN, Murphy MF, Jairath V.

Lancet Gastroenterol Hepatol. 2017 May;2(5):354-360. doi: 10.1016/S2468-1253(17)30054-7. Epub 2017 Mar 23. Review.

PMID:
28397699
8.

A national cluster-randomised controlled trial to examine the effect of enhanced reminders on the socioeconomic gradient in uptake in bowel cancer screening.

Raine R, Moss SM, von Wagner C, Atkin W, Hans IK, Howe R, Solmi F, Morris S, Counsell N, Hackshaw A, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Seaman H, Thomas M, Smith SG, McGregor LM, Vart G, Wardle J, Duffy SW.

Br J Cancer. 2016 Dec 6;115(12):1479-1486. doi: 10.1038/bjc.2016.365. Epub 2016 Nov 22.

9.

Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial.

McGregor LM, von Wagner C, Atkin W, Kralj-Hans I, Halloran SP, Handley G, Logan RF, Rainbow S, Smith S, Snowball J, Thomas MC, Smith SG, Vart G, Howe R, Counsell N, Hackshaw A, Morris S, Duffy SW, Raine R, Wardle J.

Gastroenterol Res Pract. 2016;2016:3670150. doi: 10.1155/2016/3670150. Epub 2016 Mar 16.

10.

Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.

Raine R, Duffy SW, Wardle J, Solmi F, Morris S, Howe R, Kralj-Hans I, Snowball J, Counsell N, Moss S, Hackshaw A, von Wagner C, Vart G, McGregor LM, Smith SG, Halloran S, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Atkin W.

Br J Cancer. 2016 Feb 2;114(3):321-6. doi: 10.1038/bjc.2015.413. Epub 2016 Jan 7.

11.

Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials.

Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, Vart G, Howe R, Snowball J, Handley G, Logan RF, Rainbow S, Smith S, Thomas MC, Counsell N, Morris S, Duffy SW, Hackshaw A, Moss S, Atkin W, Raine R.

Lancet. 2016 Feb 20;387(10020):751-9. doi: 10.1016/S0140-6736(15)01154-X. Epub 2015 Dec 9.

12.

Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewelyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Lancet. 2015 Jul 11;386(9989):137-44. doi: 10.1016/S0140-6736(14)61999-1. Epub 2015 May 5.

PMID:
25956718
13.

Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.

Campbell HE, Stokes EA, Bargo D, Logan RF, Mora A, Hodge R, Gray A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Dyer C, Llewelyn C, Walsh TS, Travis SP, Murphy MF, Jairath V; TRIGGER investigators.

BMJ Open. 2015 Apr 29;5(4):e007230. doi: 10.1136/bmjopen-2014-007230.

14.

Comment on impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.

Logan RF, Halloran SP.

Gut. 2015 Jun;64(6):1006-7. doi: 10.1136/gutjnl-2014-308902. Epub 2014 Dec 15. No abstract available.

PMID:
25512640
15.

Poor outcomes in hospitalized patients with gastrointestinal bleeding: impact of baseline risk, bleeding severity, and process of care.

Jairath V, Thompson J, Kahan BC, Daniel R, Hearnshaw SA, Travis SP, Murphy MF, Palmer KR, Logan RF.

Am J Gastroenterol. 2014 Oct;109(10):1603-12. doi: 10.1038/ajg.2014.263. Epub 2014 Aug 26.

PMID:
25155225
17.

Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial.

Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, Dyer C, Stokes EA, Llewelyn C, Bailey AA, Dallal H, Everett SM, James MW, Stanley AJ, Church N, Darwent M, Greenaway J, Le Jeune I, Reckless I, Campbell HE, Meredith S, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF.

Transfus Med Rev. 2013 Jul;27(3):146-53. doi: 10.1016/j.tmrv.2013.04.001. Epub 2013 May 22.

18.

Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.

Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, Galan P, Bønaa KH, Jamison R, Gaziano JM, Guarino P, Baron JA, Logan RF, Giovannucci EL, den Heijer M, Ueland PM, Bennett D, Collins R, Peto R; B-Vitamin Treatment Trialists' Collaboration.

Lancet. 2013 Mar 23;381(9871):1029-36.

19.

ACP Journal Club. A single FIT (≥ 50 ng Hb/mL) detected 38% of screen-detected advanced colorectal neoplasia.

Logan RF.

Ann Intern Med. 2012 Nov 20;157(10):JC5-10. doi: 10.7326/0003-4819-157-10-201211200-02010. No abstract available.

PMID:
23165686
20.

National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding.

Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Dore CJ, Travis SP, Murphy MF, Palmer KR.

Br J Surg. 2012 Dec;99(12):1672-80. doi: 10.1002/bjs.8932. Epub 2012 Sep 28.

PMID:
23023268
21.

Prevalence, management, and outcomes of patients with coagulopathy after acute nonvariceal upper gastrointestinal bleeding in the United Kingdom.

Jairath V, Kahan BC, Stanworth SJ, Logan RF, Hearnshaw SA, Travis SP, Palmer KR, Murphy MF.

Transfusion. 2013 May;53(5):1069-76. doi: 10.1111/j.1537-2995.2012.03849.x. Epub 2012 Aug 15.

PMID:
22897615
22.
23.

Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.

Morris S, Baio G, Kendall E, von Wagner C, Wardle J, Atkin W, Halloran SP, Handley G, Logan RF, Obichere A, Rainbow S, Smith S, Snowball J, Raine R.

Br J Cancer. 2012 Aug 21;107(5):765-71. doi: 10.1038/bjc.2012.303. Epub 2012 Aug 2.

24.

Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study.

Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Doré CJ, Travis SP, Murphy MF, Palmer KR.

Endoscopy. 2012 Aug;44(8):723-30. doi: 10.1055/s-0032-1309736. Epub 2012 Jul 2.

PMID:
22752889
25.

What predicts failed cannulation and therapy at ERCP? Results of a large-scale multicenter analysis.

Williams EJ, Ogollah R, Thomas P, Logan RF, Martin D, Wilkinson ML, Lombard M.

Endoscopy. 2012 Jul;44(7):674-83. doi: 10.1055/s-0032-1309345. Epub 2012 Jun 13.

PMID:
22696192
26.

Acute upper gastrointestinal bleeding: identifying low risk patients.

Logan RF, Hearnshaw S, Lowe D, Travis SP, Murphy MS, Palmer KR.

Gut. 2012 Nov;61(11):1641. Epub 2012 Mar 2. No abstract available.

PMID:
22387528
27.

The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study.

Grainge MJ, West J, Solaymani-Dodaran M, Card TR, Logan RF.

Aliment Pharmacol Ther. 2012 Mar;35(6):730-9. doi: 10.1111/j.1365-2036.2012.04998.x. Epub 2012 Jan 30.

28.

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.

Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C; English Bowel Cancer Screening Evaluation Committee.

Gut. 2012 Oct;61(10):1439-46. Epub 2011 Dec 7.

29.

Chemoprevention of colorectal cancer in inflammatory bowel disease.

Subramanian V, Logan RF.

Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):593-606. doi: 10.1016/j.bpg.2011.09.003. Review.

PMID:
22122774
30.

Chemoprevention in gastroenterology.

Hull M, Logan RF.

Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):443. doi: 10.1016/j.bpg.2011.10.014. No abstract available.

PMID:
22122761
31.

Aspirin in the chemoprevention of colorectal neoplasia: an overview.

Chan AT, Arber N, Burn J, Chia WK, Elwood P, Hull MA, Logan RF, Rothwell PM, Schrör K, Baron JA.

Cancer Prev Res (Phila). 2012 Feb;5(2):164-78. doi: 10.1158/1940-6207.CAPR-11-0391. Epub 2011 Nov 14. Review.

32.

No difference in mortality in undetected coeliac disease compared with the general population: a UK cohort study.

Canavan C, Logan RF, Khaw KT, West J.

Aliment Pharmacol Ther. 2011 Oct;34(8):1012-9. doi: 10.1111/j.1365-2036.2011.04811.x. Epub 2011 Aug 17.

33.

Mortality from acute upper gastrointestinal bleeding in the United kingdom: does it display a "weekend effect"?

Jairath V, Kahan BC, Logan RF, Hearnshaw SA, Travis SP, Murphy MF, Palmer KR.

Am J Gastroenterol. 2011 Sep;106(9):1621-8. doi: 10.1038/ajg.2011.172. Epub 2011 May 24.

PMID:
21606977
34.

Red blood cell transfusion practice in patients presenting with acute upper gastrointestinal bleeding: a survey of 815 UK clinicians.

Jairath V, Kahan BC, Logan RF, Travis SP, Palmer KR, Murphy MF.

Transfusion. 2011 Sep;51(9):1940-8. doi: 10.1111/j.1537-2995.2011.03119.x. Epub 2011 Mar 24.

PMID:
21585395
35.

Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit.

Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR.

Gut. 2011 Oct;60(10):1327-35. doi: 10.1136/gut.2010.228437. Epub 2011 Apr 13.

PMID:
21490373
36.

Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.

von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J.

Int J Epidemiol. 2011 Jun;40(3):712-8. doi: 10.1093/ije/dyr008. Epub 2011 Feb 17.

PMID:
21330344
37.

Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials.

Figueiredo JC, Mott LA, Giovannucci E, Wu K, Cole B, Grainge MJ, Logan RF, Baron JA.

Int J Cancer. 2011 Jul 1;129(1):192-203. doi: 10.1002/ijc.25872. Epub 2011 Apr 1.

38.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

39.

Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding.

Hearnshaw SA, Logan RF, Palmer KR, Card TR, Travis SP, Murphy MF.

Aliment Pharmacol Ther. 2010 Jul;32(2):215-24. doi: 10.1111/j.1365-2036.2010.04348.x. Epub 2010 May 5.

40.

Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis.

Papaioannou D, Cooper KL, Carroll C, Hind D, Squires H, Tappenden P, Logan RF.

Colorectal Dis. 2011 Oct;13(10):1085-99. doi: 10.1111/j.1463-1318.2010.02289.x. Epub 2010 Apr 19. Review.

PMID:
20412095
41.

Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit.

Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR.

Gut. 2010 Aug;59(8):1022-9. doi: 10.1136/gut.2008.174599. Epub 2010 Mar 31.

PMID:
20357318
42.

Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment.

Lewis NR, Sanders DS, Logan RF, Fleming KM, Hubbard RB, West J.

Br J Nutr. 2009 Aug;102(4):509-13. doi: 10.1017/S0007114509297248.

PMID:
19660152
43.

Consenting patients for endoscopic retrograde cholangiopancreatography: results of a survey of 182 UK endoscopists and 2059 of their patients.

Williams EJ, Hamlyn A, Logan RF, Martin D, Wilkinson ML, Lombard M.

Eur J Gastroenterol Hepatol. 2009 Dec;21(12):1351-7. doi: 10.1097/MEG.0b013e328305e175.

PMID:
19525853
44.

Malignancy in unrecognised coeliac disease: a nail in the coffin for mass screening?

Logan RF.

Gut. 2009 May;58(5):618-9. doi: 10.1136/gut.2008.161182. No abstract available.

PMID:
19359431
45.

Patient perceptions of the burden of coeliac disease and its treatment in the UK.

Whitaker JK, West J, Holmes GK, Logan RF.

Aliment Pharmacol Ther. 2009 May 15;29(10):1131-6. doi: 10.1111/j.1365-2036.2009.03983.x. Epub 2009 Feb 26.

46.

Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ, Chaussade S, Baron JA.

J Natl Cancer Inst. 2009 Feb 18;101(4):256-66. doi: 10.1093/jnci/djn485. Epub 2009 Feb 10.

47.

Review: faecal occult blood test screening reduces risk of colorectal cancer mortality.

Logan RF.

Evid Based Med. 2009 Feb;14(1):15. doi: 10.1136/ebm.14.1.15. No abstract available.

PMID:
19181947
48.

What is the peak age for onset of IBD?

Johnston RD, Logan RF.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S4-5. doi: 10.1002/ibd.20545. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816745
49.

How often is IBD diagnosed incidentally at screening colonoscopy done for colorectal cancer surveillance or other reasons?

Johnston RD, Logan RF.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S170-1. doi: 10.1002/ibd.20596. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816715
50.

Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.

Duggan AE, Elliott CA, Miller P, Hawkey CJ, Logan RF.

Aliment Pharmacol Ther. 2009 Jan;29(1):55-68. doi: 10.1111/j.1365-2036.2008.03852.x. Epub 2008 Sep 17.

Supplemental Content

Loading ...
Support Center